Ledger.Open graph →
SEC Form D · filed January 26, 2015

IGENICA BIOTHERAPEUTICS, INC

Offering
$6.3M
Sold
$5.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BURLINGAME, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

John Celebi · Burlingame, CAExecErnst Bergen · Lemont, ILDirectorCustodial Trustee The Northern Trust Company · Chicago, ILDirectorCarl Gordon · New York, NYDirectorDavid Rowe · Boca Raton, FLDirectorDavid Kushner · New York, NYDirectorMark Goldsmith · Burlingame, CADirectorAndrew N. Dakos · Saddle Brook, NJDirectorKeval Desai · Menlo Park, CADirectorRobert Schreiber · Burlingame, CADirectorRyan Rients · SIOUX FALLS, SDExec · DirectorMathias Schilling · San Francisco, CADirectorDavid Goeddel · San Francisco, CADirectorGwen Fyfe · Burlingame, CADirectorJohn Diekman · Menlo Park, CADirectorChris Dimock · Cody, WYDirectorMartin Jaszczuk · Lemont, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗